廣東和信健康科技有限公司成立于2015年4月，注冊(cè)資本6232.543萬元。 公司是鐘南山院士產(chǎn)學(xué)研團(tuán)隊(duì)、國(guó)家呼吸系統(tǒng)疾病臨床醫(yī)學(xué)研究中心產(chǎn)學(xué)研分中心、以及傳染病診斷試劑產(chǎn)業(yè)技術(shù)創(chuàng)新聯(lián)盟重要成員單位。和信公司位于呼吸疾病國(guó)家實(shí)驗(yàn)室（國(guó)內(nèi)的呼吸科研究機(jī)構(gòu)）產(chǎn)學(xué)研基地內(nèi)的高新技術(shù)企業(yè)，擁有5000平方自主研發(fā)、生產(chǎn)場(chǎng)地，主要從事呼吸道傳染病診斷試劑研發(fā)及產(chǎn)業(yè)化，公司成立的研發(fā)中心被評(píng)為廣東省呼吸道病毒診斷試劑工程技術(shù)研究中心，并通過廣州市研發(fā)機(jī)構(gòu)建設(shè)的認(rèn)定。公司以李小鋒博士的為首的創(chuàng)業(yè)團(tuán)隊(duì)獲得了廣州市創(chuàng)業(yè)團(tuán)隊(duì)，并獲得了和社會(huì)的大力支持。自公司成立以來，始終堅(jiān)持自主研發(fā)、自主創(chuàng)新理念，以保障人類呼吸健康為使命，未來將深耕呼吸道傳染性疾病診斷技術(shù)，提供﹑多平臺(tái)診斷產(chǎn)品，成為呼吸道疾病診斷方法和解決方案全面提供商，將公司打造成國(guó)內(nèi)呼吸道傳染病診斷。 Guangdong Hecin Scientific Inc. was established in April 2015 with a registered capital of 62,235,430,000 yuan. The company is a high and new technology enterprise of Zhong Nanshan Academician Industry-Academy-Research Team, Industry-Academy-Research Branch Center of National Clinical Medical Research Center for Respiratory Diseases, as well as an important member of Infectious Disease Diagnostic Reagent Industry Technology Innovation Alliance. Hecin is located in a high-tech enterprise located in the State Key Lab. of Respiratory Disease (famous respiratory research institutions in China). It has 5000 square meters of R & D and production sites, mainly engaged in R & D and industrialization of diagnostic reagents for respiratory infectious diseases. 聯(lián)系人：黃小姐